Evidence map›Paper›PMID 41953023›Full record

ArticleFrontiers in immunology2026

Correction: Clinical outcomes and early- prognostic biomarkers of primary biliary cholangitis with ductopenia.

Wenjuan Wang, Guo Zhang, Hui Liu, Lingna Lv, Jing Chang, Zefeng Liu, Huilan Ye, Huiguo Ding, Ying Han

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Wenjuan Wang *Department of Gastroenterology, Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-Sen University, Nanning, Guangxi, China.
Guo Zhang *Department of Gastroenterology, Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-Sen University, Nanning, Guangxi, China.
Hui LiuDepartment of Pathology, Laboratory for Clinical Medicine, Beijing You`an Hospital, Capital Medical University, Beijing, China.
Lingna LvDepartment of Gastroenterology and Hepatology, Laboratory for Clinical Medicine, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Jing ChangDepartment of Pathology, Laboratory for Clinical Medicine, Beijing You`an Hospital, Capital Medical University, Beijing, China.
Zefeng LiuDepartment of Gastroenterology, Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-Sen University, Nanning, Guangxi, China.
Huilan YeDepartment of Gastroenterology, Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-Sen University, Nanning, Guangxi, China.
Huiguo Ding *Department of Gastroenterology and Hepatology, Laboratory for Clinical Medicine, Beijing You'an Hospital, Capital Medical University, Beijing, China.
Ying Han *Department of Gastroenterology and Hepatology, Laboratory for Clinical Medicine, Beijing You'an Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2025.1680942.].

Indexed as

alkaline phosphataseantinuclear antibodiesbiomarkersclinical featuresductopeniagamma-glutamyl transferaseprimary biliary cholangitisprognosis

Identifiers

PMID41953023
PMCPMC13055224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.